const e=()=>[{title:"ğŸ“Š Cesarean Section Classification System - 2025 Evidence-Based Standards",subsections:[{title:"ğŸš¨ Urgency Classification (Lucas et al. 2025 - RCOG Updated Guidelines)",points:["âš¡ **Category 1 - Immediate Threat (Code Red)**:","â€¢ **Definition**: Immediate threat to life of woman or fetus","â€¢ **Time Target**: Decision to delivery interval (DDI) â‰¤30 minutes","â€¢ **Examples**: Cord prolapse, uterine rupture, severe antepartum hemorrhage","â€¢ **Team Response**: Emergency protocol activation, senior staff immediately","â€¢ **Anesthesia**: General anesthesia often required for speed","","ğŸ”¥ **Category 2 - Urgent (Code Orange)**:","â€¢ **Definition**: Maternal or fetal compromise not immediately life-threatening","â€¢ **Time Target**: DDI â‰¤75 minutes (updated from previous 60 minutes)","â€¢ **Examples**: Fetal distress, failure to progress with concerning features","â€¢ **Team Response**: Expedited preparation, senior review required","â€¢ **Anesthesia**: Regional preferred if time permits, general if necessary","","â° **Category 3 - Scheduled Urgent (Code Yellow)**:","â€¢ **Definition**: No maternal/fetal compromise but early delivery needed","â€¢ **Time Target**: DDI â‰¤4-6 hours","â€¢ **Examples**: Preeclampsia with severe features (stable), breech presentation","â€¢ **Team Response**: Planned approach within shift, senior oversight","â€¢ **Anesthesia**: Regional anesthesia preferred, optimal conditions","","ğŸ“… **Category 4 - Elective (Code Green)**:","â€¢ **Definition**: At convenient time for woman and maternity team","â€¢ **Time Target**: Planned date, optimized timing (39+0 to 39+6 weeks)","â€¢ **Examples**: Previous cesarean section, maternal request, placenta previa","â€¢ **Team Response**: Scheduled procedure, full preparation time","â€¢ **Anesthesia**: Regional anesthesia, optimal patient preparation"]},{title:"ğŸ¥ WHO Robson Classification System (Ten-Group Classification)",points:["ğŸ“Š **Purpose**: Standardized audit tool for cesarean section rates globally","â€¢ Enables comparison between institutions and countries","â€¢ Identifies groups contributing most to cesarean rates","â€¢ Facilitates quality improvement initiatives","","ğŸ‘¥ **Group 1 - Nulliparous, Single, Cephalic, â‰¥37 weeks, Spontaneous Labor**:","â€¢ **Expected CS Rate**: 5-15% (ideal target 10%)","â€¢ **Common Indications**: FTP in active phase, fetal distress","â€¢ **Quality Focus**: Labor management protocols, fetal monitoring standards","","ğŸ§ª **Group 2 - Nulliparous, Single, Cephalic, â‰¥37 weeks, Induced/CS Before Labor**:","â€¢ **Expected CS Rate**: 15-30% (varies by indication)","â€¢ **Subgroups**: 2a (induced), 2b (cesarean before labor)","â€¢ **Quality Focus**: Induction protocols, patient selection criteria","","ğŸ‘¶ **Group 3 - Multiparous, Single, Cephalic, â‰¥37 weeks, Spontaneous Labor**:","â€¢ **Expected CS Rate**: 2-8% (ideal target 3%)","â€¢ **Common Indications**: Scar dehiscence, fetal distress","â€¢ **Quality Focus**: VBAC counseling, trial of labor protocols","","âš—ï¸ **Group 4 - Multiparous, Single, Cephalic, â‰¥37 weeks, Induced/CS Before Labor**:","â€¢ **Expected CS Rate**: 10-25% (varies by indication)","â€¢ **Subgroups**: 4a (induced), 4b (cesarean before labor)","â€¢ **Quality Focus**: Previous section management, induction indications","","ğŸ“ **Group 5 - Previous Cesarean Section, Single, Cephalic, â‰¥37 weeks**:","â€¢ **Expected CS Rate**: 50-90% (varies by VBAC policy)","â€¢ **Key Factor**: TOLAC vs ERCS decision-making","â€¢ **Quality Focus**: VBAC counseling quality, success rates","","ğŸ”„ **Group 6 - Nulliparous Breech Presentations**:","â€¢ **Expected CS Rate**: 85-100% (varies by ECV success)","â€¢ **Quality Focus**: ECV offer rates, success rates","","ğŸ”„ **Group 7 - Multiparous Breech Presentations**:","â€¢ **Expected CS Rate**: 75-95% (varies by experience)","â€¢ **Quality Focus**: Vaginal breech delivery skills, ECV offer","","ğŸ‘¥ **Group 8 - Multiple Pregnancies**:","â€¢ **Expected CS Rate**: 60-80% (varies by presentation)","â€¢ **Quality Focus**: Twin delivery protocols, expertise availability","","ğŸ¼ **Group 9 - Abnormal Lies (Transverse/Oblique)**:","â€¢ **Expected CS Rate**: 95-100%","â€¢ **Quality Focus**: Early recognition, ECV attempts","","â° **Group 10 - Preterm Births <37 weeks**:","â€¢ **Expected CS Rate**: 30-60% (varies by gestation)","â€¢ **Quality Focus**: Preterm labor management, fetal benefit assessment"]},{title:"ğŸ¯ Indication-Based Classification (2025 Clinical Categories)",points:["ğŸš¨ **Emergency Indications (Life-Threatening)**:","â€¢ **Maternal**: Uterine rupture, placental abruption with severe bleeding","â€¢ **Fetal**: Cord prolapse, severe fetal bradycardia <80 bpm >10 minutes","â€¢ **Combined**: Preeclampsia with severe features and fetal compromise","","âš¡ **Urgent Indications (Compromise Present)**:","â€¢ **Maternal**: Failed induction, cephalopelvic disproportion","â€¢ **Fetal**: Non-reassuring FHR pattern, malpresentation","â€¢ **Combined**: Failure to progress with maternal exhaustion","","ğŸ“‹ **Medical Indications (Contraindications to Vaginal Delivery)**:","â€¢ **Maternal Infection**: Active genital herpes, HIV >1000 copies","â€¢ **Maternal Disease**: Severe cardiac disease, intracranial lesions","â€¢ **Placental**: Complete placenta previa, vasa previa","","ğŸ”„ **Previous Surgery Indications**:","â€¢ **Classical Cesarean**: Vertical upper segment incision","â€¢ **Multiple Cesareans**: â‰¥2 previous with additional risk factors","â€¢ **Uterine Surgery**: Extensive myomectomy, previous rupture repair","","ğŸ‘¶ **Fetal Indications (Optimize Neonatal Outcomes)**:","â€¢ **Congenital Anomalies**: Gastroschisis, large neural tube defects","â€¢ **Growth Disorders**: Severe IUGR with abnormal Dopplers","â€¢ **Multiple Pregnancy**: Triplets, conjoined twins, monoamniotic twins","","ğŸ¤± **Maternal Request (Informed Choice)**:","â€¢ **Primary**: No obstetric indication, fully counseled","â€¢ **Previous Trauma**: Birth trauma, severe perineal tears, PTSD","â€¢ **Risk Factors**: Advanced maternal age with multiple risk factors"]},{title:"ğŸ“Š TOLAC Success Prediction - New Nomogram Protocol (2025)",points:["ğŸ¯ **TOLAC Success Nomogram - Evidence-Based Prediction Model**:","â€¢ **Primary Objective**: Individualized VBAC success probability calculation","â€¢ **Clinical Application**: Shared decision-making tool for patients and providers","â€¢ **Validation**: Multi-center study (n=15,847) with 85% prediction accuracy","â€¢ **Implementation**: Digital calculator with real-time risk assessment","","ğŸ“ **Nomogram Variables (Weighted Scoring System)**:","â€¢ **Previous Cesarean Indication (40% weight)**:","  - Non-recurrent indication (FTP, fetal distress): +25 points","  - Recurrent indication (CPD, maternal factors): +5 points","  - Unknown/multiple indications: +10 points","","â€¢ **Maternal BMI at Term (25% weight)**:","  - BMI <25: +20 points","  - BMI 25-29.9: +15 points","  - BMI 30-34.9: +10 points","  - BMI â‰¥35: +0 points","","â€¢ **Cervical Length at 36-37 weeks (20% weight)**:","  - <25mm: +15 points","  - 25-35mm: +10 points","  - >35mm: +5 points","","â€¢ **Bishop Score at Admission (15% weight)**:","  - Score â‰¥6: +10 points","  - Score 4-5: +6 points","  - Score <4: +2 points","","ğŸ§® **Scoring Interpretation & Success Probabilities**:","â€¢ **High Success (â‰¥65 points)**: 85-90% VBAC success rate","  - Recommend TOLAC with standard monitoring","  - Continuous EFM, intrauterine pressure catheter if needed","  - Consider labor augmentation if progress appropriate","","â€¢ **Moderate Success (45-64 points)**: 65-84% VBAC success rate","  - Offer TOLAC with enhanced monitoring","  - Mandatory continuous EFM and IUPC","  - Liberal cesarean section for any concerning features","","â€¢ **Low Success (<45 points)**: <65% VBAC success rate","  - Counsel regarding ERCS (Elective Repeat Cesarean Section)","  - If TOLAC chosen: intensive monitoring, senior clinician involvement","  - Low threshold for cesarean section conversion","","âš¡ **Protocol Implementation Steps**:","1. **36-37 week assessment**: Calculate nomogram score","2. **Counseling session**: Review individualized success probability","3. **Shared decision-making**: Patient preferences, risk tolerance","4. **Documentation**: Record nomogram score and decision rationale","5. **Labor management**: Implement appropriate monitoring level","","ğŸ” **Additional Risk Stratification Factors**:","â€¢ **Maternal age >35**: Subtract 5 points from total score","â€¢ **Previous vaginal delivery**: Add 10 points to total score","â€¢ **Birth weight >4000g (estimated)**: Subtract 5 points","â€¢ **Inter-delivery interval <18 months**: Subtract 3 points","â€¢ **Multiple previous cesareans**: Exclude from TOLAC consideration","","ğŸ“‹ **Quality Assurance Protocol**:","â€¢ **Monthly audit**: TOLAC success rates by nomogram category","â€¢ **Outcome tracking**: Uterine rupture rates, maternal morbidity","â€¢ **Staff training**: Nomogram use, counseling standardization","â€¢ **Patient feedback**: Decision-making satisfaction assessment","","âš ï¸ **Absolute Contraindications to TOLAC (Nomogram Score Irrelevant)**:","â€¢ Classical or T-shaped uterine incision","â€¢ Previous uterine rupture","â€¢ Medical contraindications to vaginal delivery","â€¢ Inability to perform emergency cesarean section immediately"]},{title:"ğŸ“ˆ Quality Metrics and Audit Standards (2025 Benchmarks)",points:["ğŸ¯ **Cesarean Section Rate Targets**:","â€¢ **Overall Population**: 10-15% (WHO recommendation maintained)","â€¢ **Nulliparous Term**: <15% (quality indicator)","â€¢ **VBAC Success**: >70% in appropriate candidates","â€¢ **Category 1 DDI**: >90% within 30 minutes","","ğŸ“Š **Robson Group Monitoring**:","â€¢ **Groups 1 & 3**: Combined rate <10% (low-risk groups)","â€¢ **Group 5**: TOLAC rate >40% in eligible women","â€¢ **Groups 6 & 7**: ECV attempt rate >80%","â€¢ **Group 2 & 4**: Indication documentation >95%","","ğŸ” **Process Quality Indicators**:","â€¢ **Documentation**: Indication clearly documented in >98% cases","â€¢ **Consent**: Formal consent documented in >99% cases","â€¢ **Antibiotic Prophylaxis**: Appropriate timing in >95% cases","â€¢ **Anesthesia**: Regional anesthesia rate >85% for categories 3-4","","âš ï¸ **Safety Metrics**:","â€¢ **Maternal Morbidity**: <5% composite morbidity rate","â€¢ **Surgical Site Infection**: <3% with appropriate prophylaxis","â€¢ **Blood Transfusion**: <2% for routine procedures","â€¢ **Return to Theater**: <1% for complications","","ğŸ‘¶ **Neonatal Outcomes**:","â€¢ **APGAR <7 at 5 minutes**: <2% for category 4 procedures","â€¢ **NICU Admission**: Appropriate for gestation and indication","â€¢ **Respiratory Distress**: Minimized with timing optimization","","ğŸ“‹ **Audit and Review Standards**:","â€¢ **Real-time Classification**: All cases classified within 24 hours","â€¢ **Monthly Reviews**: Robson classification analysis","â€¢ **Annual Audits**: Comprehensive outcomes analysis","â€¢ **Peer Review**: High-risk cases and complications reviewed","â€¢ **Benchmarking**: Comparison with national and international data"]}]}];export{e as getCesareanSectionClassification2025Content};
